US 12233124
Recombinant metapneumovirus f proteins and their use
granted A61KA61K39/155A61K39/39
Quick answer
US patent 12233124 (Recombinant metapneumovirus f proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K39/155, A61K39/39, A61K48/00